These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2044374)

  • 21. Allergic reactions to Merthiolate (Thimerosal).
    Fisher AA
    Cutis; 1981 Jun; 27(6):580, 582, 587. PubMed ID: 6453701
    [No Abstract]   [Full Text] [Related]  

  • 22. Neonate exposure to thimerosal mercury from hepatitis B vaccines.
    Dórea JG; Marques RC; Brandão KG
    Am J Perinatol; 2009 Aug; 26(7):523-7. PubMed ID: 19283656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of the efficiency of tick-borne encephalitis vaccination in the population in the natural foci of Austria].
    Heinz F; Holtzmann H; Essl A; Kundt M
    Vopr Virusol; 2008; 53(2):19-27. PubMed ID: 18450105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiomersal sensitivity in health care workers.
    Rees S; Gibson J; Forsyth A; Wray D
    Br Dent J; 1997 Dec 13-27; 183(11-12):395. PubMed ID: 9447766
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinically Relevant Reactions to Thimerosal (the "Nonallergen") Exist!
    Aschenbeck KA; Warshaw EM
    Dermatitis; 2018; 29(1):44-45. PubMed ID: 28538009
    [No Abstract]   [Full Text] [Related]  

  • 26. Hyposensitizing therapy with standard antigenic extracts: an important source of thimerosal sensitization.
    Tosti A; Guerra L; Bardazzi F
    Contact Dermatitis; 1989 Mar; 20(3):173-6. PubMed ID: 2721183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thimerosal: current sources of contact in Brazil.
    Rocha VB; Scherrer MA
    An Bras Dermatol; 2014; 89(2):376-8. PubMed ID: 24770530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reactions to thimerosal in hepatitis B vaccines.
    Rietschel RL; Adams RM
    Dermatol Clin; 1990 Jan; 8(1):161-4. PubMed ID: 2137393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices.
    Hurie MB; Saari TN; Davis JP
    Pediatrics; 2001 Apr; 107(4):755-8. PubMed ID: 11335754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines.
    Tozzi AE; Bisiacchi P; Tarantino V; De Mei B; D'Elia L; Chiarotti F; Salmaso S
    Pediatrics; 2009 Feb; 123(2):475-82. PubMed ID: 19171612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thimerosal--is it really irrelevant?
    Slodownik D; Ingber A
    Contact Dermatitis; 2005 Dec; 53(6):324-6. PubMed ID: 16364119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Source and clinical significance of allergy for thiomersal, an organic mercury compound].
    van 't Veen AJ; van Joost T
    Ned Tijdschr Geneeskd; 1996 Feb; 140(6):297-300. PubMed ID: 8720702
    [No Abstract]   [Full Text] [Related]  

  • 34. [Addressing the controversy regarding the association between thimerosal-containing vaccines and autism].
    García-Fernández L; Hernández AV; Suárez Moreno V; Fiestas F
    Rev Peru Med Exp Salud Publica; 2013 Apr; 30(2):268-74. PubMed ID: 23949514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiomersal.
    Wilkinson DS
    Contact Dermatitis; 1979 Jan; 5(1):58-9. PubMed ID: 421465
    [No Abstract]   [Full Text] [Related]  

  • 36. Patch test reactions in children, adults and the elderly. A comparative study in patients with suspected allergic contact dermatitis.
    Wantke F; Hemmer W; Jarisch R; Götz M
    Contact Dermatitis; 1996 May; 34(5):316-9. PubMed ID: 8807222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed hypersensitivity to thimerosal in soft contact lens wearers.
    Wilson LA; McNatt J; Reitschel R
    Ophthalmology; 1981 Aug; 88(8):804-9. PubMed ID: 7322498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tick-borne encephalitis (TBE) and TBE-vaccination in Austria: Update 2014].
    Kunze U; Böhm G
    Wien Med Wochenschr; 2015 Jul; 165(13-14):290-5. PubMed ID: 26055812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contact sensitization to thimerosal in healthy subjects].
    Seidenari S; Manzini BM; Modenese M; Danese P
    G Ital Dermatol Venereol; 1989; 124(7-8):335-9. PubMed ID: 2534118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half-time to infants.
    Magos L
    J Appl Toxicol; 2003; 23(4):263-9. PubMed ID: 12884410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.